Hit enter to search or ESC to close
NuView Life SciencesNuView Life SciencesNuView Life SciencesNuView Life Sciences
  • Home
  • About Us
    • Mission
    • Leadership
      • Management Team
      • Directors
      • Clinical Collaborators
  • Diagnostics
    • In Vivo Diagnostics
    • In Vitro Diagnostics
    • Theranostics Applications
    • Why Research for New Diagnostics?
  • Publications
  • News
    • NuView Life Sciences in the News
    • Press Releases
  • Contact Us
NuView Life Sciences
Category

News

Sep 25
Love0

Retired US Air Force Fighter Pilots Develop Prostate Cancer at Alarming Rates

By Karla Jo Helms NuView Life Sciences in the News

Screening frequency is being questioned; Innovations needed Questions around the rise in cancers in former Air Force pilots are causing concerns about the role of…

Read More
Aug 13
Love1

New Guidelines Recommend More Frequent Breast Cancer Screening, But False Positive Results Persist

By Karla Jo Helms Press Releases

PARK CITY, Utah, August 13, 2019 /PRNewswire-PRWeb/ — The American Society of Breast Surgeons recently announced new cancer screening guidelines that are designed to help…

Read More
Jul 25
Love0

Breakthrough Precision Medicine Technology for Non-Invasive Approach to Detecting Cancer

By Karla Jo Helms NuView Life Sciences in the News

VPAC1 biomarkers are expressed on cell surfaces in high densities at the onset of oncogenesis. When VPAC1 receptors are targeted, cancer can be diagnosed early,…

Read More
Jun 06
Love0

NuView Partners With Aperture Bio on Prostate Cancer Test

By Karla Jo Helms NuView Life Sciences in the News

NEW YORK (360Dx) — NuView Life Sciences has signed an agreement to evaluate its NV-VPAC1 urogenital cancer test on Aperture Bio’s screening platform, the company…

Read More
Apr 18
Love0

VPAC1-targeted PET/CT scan: improved molecular imaging for the diagnosis of prostate cancer using a novel cell surface antigen

By Karla Jo Helms News

Current approaches to prostate cancer screening and diagnosis are plagued with limitations in diagnostic accuracy. There is a compelling need for biomolecular imaging that will…

Read More
Mar 13
Love0

Binding Cell Receptors Key to New Prostate Cancer Diagnostic Test from NuView Life Sciences

By Karla Jo Helms Press Releases

A recent study validating urine diagnosis for cancer cell receptors in prostate cancer is eclipsing traditional methodology and warrants further steps toward FDA approval says…

Read More
Nov 17
Love0

Better Solutions Needed As Cancer Drug Costs Escalate

https://bioprocessintl.com/business/economics/better-solutions-needed-cancer-drug-costs-escalate/
Aug 29
Love1

Development of Precision Cancer Diagnostics Continues Amid Booming Tumor Profiling Market

By Karla Jo Helms Press Releases

The cancer (tumor) profiling market is expected to grow at a CAGR of 19.1% over the next four years. This growth directly reflects the public’s…

Read More
Aug 21
Love0

Investing in Precision Diagnostics Drives Down Cancer Treatment +Costs

http://moneyforlunch.com/investing-in-precision-diagnostics-drives-down-cancer-treatment-costs/
Aug 17
Love0

NuView to Launch Expanded Trials to Ready Prostate Cancer Test for FDA Clearance

https://www.360dx.com/regulatory-news/nuview-launch-expanded-trials-ready-prostate-cancer-test-fda-clearance
Previous 1 2 3 4 5 Next

Categories

  • News
  • NuView Life Sciences in the News
  • Press Releases

Recent Posts

  • Delfi Diagnostics reels in $100M for blood-based cancer test
  • Radiopharmaceuticals Are Showing Promise as the Next Generation of Cancer Treatment
  • NuView Life Sciences Develops New Theranostics Approach to Offset High Cost of Cancer Diagnosis, Treatment
  • Radiopharmaceuticals Gain Traction for Cancer Theranostics Potential
  • Park City company develops new ground breaking cancer treatment

Archives

  • January 2021
  • November 2020
  • August 2020
  • June 2020
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • April 2019
  • March 2019
  • November 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016

NuView Life Sciences is a clinical stage oncology company addressing unmet medical needs.

Read More

Contact Address

NuView Life Sciences, Inc
1389 Center Drive, Suite 200
Park City, Utah 84098

Office: 435.647.9758 

Contact us:
admin@nuviewlifesciences.com

Media inquiries:
Kaden Haig
khaig@jotopr.com

The most recent press

  • NuView Life Sciences Develops New Theranostics Approach to Offset High Cost of Cancer Diagnosis, Treatment November 16, 2020
  • NuView NV-VPAC1 Uniquely Positioned to Find the Overexpression of Specific Receptors Appearing only on the Surface of Malignant Cells for Early Cancer Diagnosis August 17, 2020

Quick Links

  • Home
  • About Us
  • Products
  • News

© 2021 NuView Life Sciences. Terms of Use

  • Home
  • About Us
    • Mission
    • Leadership
      • Management Team
      • Directors
      • Clinical Collaborators
  • Diagnostics
    • In Vivo Diagnostics
    • In Vitro Diagnostics
    • Theranostics Applications
    • Why Research for New Diagnostics?
  • Publications
  • News
    • NuView Life Sciences in the News
    • Press Releases
  • Contact Us